APP and Alzheimer disease: Since Aβ peptides are derived from the proteolytic processing of the amyloid precursor protein (APP) by γ-secretase [20, 22], inhibiting the latter protease is a valuable approach that has been extensively tested in the clinic to prevent and/or delay the pathogenic effects of AD [38].